News

Read the latest news about issues affecting the neuromuscular disease community.

Illustration of DNA
Blog Post

FDA Approves AveXis’ Zolgensma for Treatment of Spinal Muscular Atrophy in Pediatric Patients

By Jeanene Swanson | May 24, 2019
Blog Post

Do You Know ALS? Read About the Latest Research.

By Jeanene Swanson | May 15, 2019
Blog Post

MDA Wins 2019 Sonia Skarlatos Public Service Award

By MDA Staff | May 8, 2019
Blog Post

FDA Approves Jacobus Pharmaceuticals’ Ruzurgi for Treatment of Children with Lambert-Eaton Myasthenic Syndrome

By Jeanene Swanson | May 8, 2019
Blog Post

Read the New MDA Manifesto

By MDA Staff | May 3, 2019
Blog Post

Progress in Motion: MDA’s 2019 Clinical & Scientific Conference Heralds New Directions for Neuromuscular Disease Treatment

By MDA Staff | May 3, 2019
Blog Post

Biogen Releases Letter to ALS Community

By MDA Staff | May 2, 2019
Blog Post

Mouse Study Finds Link Between Key Mitochondrial Protein and CMT2A, Making It a Possible Therapeutic Target

By Jeanene Swanson | May 1, 2019
Blog Post

Clinical Trial Alert: PTC Therapeutics Seeks Participants for a Phase 3 DMD Study

By MDA Staff | April 24, 2019
Blog Post

Muscular Dystrophy Association Bridges Clinical and Academic Neuromuscular Research for the First Time at Annual Meeting

By MDA Staff | April 12, 2019